Protocol No.: ICI-M-1201

Title
AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double- Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Hospitalized Participants with Immune Checkpoint Inhibitor Associated Myocarditis
Principal Investigator
Patel, Brijesh
Phase
III
Age Group
Adult
Applicable Disease Site
Heart/Cardiovascular Disease
Participating Institutions
Heart & Vascular Institute
West Virginia University
Contacts

View on ClinicalTrials.gov